Method and pharmaceutical formulation for treating benign prosta

Details Method and pharmaceutical formulation for treating benign prosta Method and pharmaceutical formulation for treating benign prosta

1997-11-24

2000-04-11

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31405

Patent

active

060488883

ABSTRACT:
Benign prostatic hyperplasia (BPH) in male humans is treated by administering to a male patient in which such condition has been diagnosed, an effective BPH treating amount within the range of from 1 ng to 80 mg of melatonin, which may be in the form of a pharmaceutical formulation for use in treating BPH, which comprises, in combination a carrier, diluent or adjuvant, (1) an effective BPH treating amount of melatonin; and optionally (2) antiandrogens, antiestrogens, growth hormones and/or inhibitors of prostatal testosterone reductase; and/or (3) oxazepam or other melatonin receptor profile modifier.

REFERENCES:
patent: 4600723 (1986-07-01), Short et al.
patent: 4654361 (1987-03-01), Samples et al.
patent: 4945103 (1990-07-01), Cohen
patent: 5196435 (1993-03-01), Clemens et al.
Laudon et al., Neuroendocrinology, 48, 577, 1988.
Chemical Abstracts 97: 66816e (1982).
Yamada, Chem. Pharm. Bull., vol. 40, pp. 1066-1068, 1988.
Laudon et al., J. Endocrinol., vol. 116, No. 1, 1988, pp. 43-53.
Moguilevsky et al., Proc. Soc. Exp. Biol. Med., vol. 151, No. 4, 1976, pp. 663-666.
Srivilai et al., J. Pineal Res., vol. 6, No. 2, 1989, pp. 111-119.
Horst et al., Horm. Metabol. Res., vol. 14, p. 54, 1982.
Guess, Epidemiologic Reviews, vol. 14, pp. 131 et seq., 1992.
Walsh et al., J. Clinical Investigation, vol. 72, Nov. 1983, pp. 1772-1777.

Affiliated with

Also associated with

Rating

Method and pharmaceutical formulation for treating benign prosta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and pharmaceutical formulation for treating benign prosta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and pharmaceutical formulation for treating benign prosta will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1177034